Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chronic obstructive pulmonary disease international guidelines

L Fabbri¹, G Caramori, B Beghe

¹Dipartmento di Medicina Clinica e Sperimentale, Universita di Ferrara, Italy.

Current Opinion in Pulmonary Medicine

|June 5, 1998

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

Allergy·2026

Same author

Italian multicentre study on the management of pLeural infection and empyema: IMPLE study.

Respiratory research·2025

Same author

Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2025

Same author

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Frontiers in allergy·2025

Same author

Auto-antibodies against carbonyl-modified vimentin in COPD: potential role as a biomarker.

Journal of inflammation (London, England)·2025

Same author

The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2024

Same journal

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026

Same journal

Multidisciplinary approach in cardiac sarcoidosis: to biopsy or not?

Current opinion in pulmonary medicine·2026

Same journal

Low diffusion capacity in pulmonary hypertension.

Current opinion in pulmonary medicine·2026

Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026

Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026

Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026

See all related articles

This review compares chronic obstructive pulmonary disease (COPD) management guidelines from major thoracic societies, highlighting similarities and differences. Limited evidence underscores the need for more research in COPD care.

Area of Science:

Pulmonology
Clinical Practice Guidelines

Background:

Chronic obstructive pulmonary disease (COPD) is a significant public health concern, yet receives less attention than asthma.
Multiple thoracic societies have developed COPD management guidelines since 1987.

Purpose of the Study:

To review and compare the similarities and discrepancies among international COPD management guidelines.
To identify areas where evidence-based medicine is limited, stimulating further research.

Main Methods:

Comparative analysis of COPD management guidelines from the American Thoracic Society, Canadian Thoracic Society, European Respiratory Society, Thoracic Society of Australia and New Zealand, and British Thoracic Society.
Identification of common themes and divergent recommendations within these guidelines.

Related Experiment Videos

Main Results:

Key COPD guidelines exhibit both commonalities and notable differences in their recommendations.
The development of these guidelines spans from 1987 to 1997, with updates and expansions.

Conclusions:

International COPD guidelines share commonalities but also present distinct approaches to management.
A significant limitation across all guidelines is the scarcity of robust evidence-based medicine, emphasizing the need for continued research in COPD.